PCM
LEGN icon

Pinz Capital Management’s Legend Biotech LEGN Stock Holding History

Pinz Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-700
Closed -$29K – 282
2021
Q2 		$29K Buy
+700
New +$23.8K 0.01% 303
2020
Q3 		– Sell
-30,000
Closed -$1.28M – 156
2020
Q2 		$1.28M Buy
+30,000
New +$1.17M 0.59% 86

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Pinz Capital Management's LEGN Position: Q3 2021 in Review

Pinz Capital Management sold out of Legend Biotech (LEGN) in Q3 2021, closing a stake of 700 shares — an estimated $29K sold.

Pinz Capital Management first reported a position in LEGN in Q2 2020 and held it in 2 quarters. The position peaked at $1.28M in Q2 2020. 88 funds tracked by Wall St. Rank hold LEGN as of Q3 2021.

  • Pinz Capital Management reported no remaining Legend Biotech position as of Q3 2021 after selling out during the quarter.
  • Pinz Capital Management sold 700 Legend Biotech shares in Q3 2021, an estimated $29K.
  • Pinz Capital Management first reported a position in Legend Biotech in Q2 2020 and held it in 2 quarters.
  • Pinz Capital Management's Legend Biotech position peaked at $1.28M in Q2 2020.
  • 88 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.